1. M.S. Pombo-De-Oliveira, F.G. Andrade, G.D. Brisson, et al., Acute myeloid leukaemia at an early age: reviewing the interaction between pesticide exposure and KMT2A-rearrangement. Ecancermedicalscience 11 (2017) 782.
2. D. Daniela, T. Mario, F. Alessandra, et al., BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Am. J. Hematol. 88 (2013) 848–852.
3. K. Wheatley, A.K. Burnett, A.H. Goldstone, et al., A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br. J. Haematol. 107 (2015) 69–79.
4. Epidemiology of childhood acute myelogenous leukemia;Bhatia;J. Pediatr. Hematol. Oncol.,1995
5. Exploiting epigenetically mediated changes: acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment;Kogan;Adv. Cancer Res.,2019